DE69132651D1 - Heterocyclic compounds containing sulfur - Google Patents

Heterocyclic compounds containing sulfur

Info

Publication number
DE69132651D1
DE69132651D1 DE69132651T DE69132651T DE69132651D1 DE 69132651 D1 DE69132651 D1 DE 69132651D1 DE 69132651 T DE69132651 T DE 69132651T DE 69132651 T DE69132651 T DE 69132651T DE 69132651 D1 DE69132651 D1 DE 69132651D1
Authority
DE
Germany
Prior art keywords
compounds containing
heterocyclic compounds
containing sulfur
optionally substituted
sulfur
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69132651T
Other languages
German (de)
Other versions
DE69132651T2 (en
Inventor
Takashi Sohda
Iwao Yamazaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DE69132651D1 publication Critical patent/DE69132651D1/en
Publication of DE69132651T2 publication Critical patent/DE69132651T2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02—Seven-membered rings
    • C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655381—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a seven-(or more) membered ring
    • C07F9/65539—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a seven-(or more) membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

A sulfur-containing heterocyclic compound of the formula (I) <CHEM> wherein the ring A is an optionally substituted benzene ring, R is a hydrogen atom or an optionally substituted hydrocarbon residue, B is a carboxyl group which may be esterified or amidated, X is -CH(OH)- or -CO-, and n is an integer of 0, 1 or 2, or its salt, which is useful in the prevention or treatment of osteoporosis.
DE69132651T 1990-05-30 1991-05-27 Heterocyclic compounds containing sulfur Expired - Fee Related DE69132651T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14194390 1990-05-30

Publications (2)

Publication Number Publication Date
DE69132651D1 true DE69132651D1 (en) 2001-08-16
DE69132651T2 DE69132651T2 (en) 2001-10-25

Family

ID=15303749

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69132651T Expired - Fee Related DE69132651T2 (en) 1990-05-30 1991-05-27 Heterocyclic compounds containing sulfur

Country Status (8)

Country Link
EP (1) EP0460488B1 (en)
JP (2) JP2992653B2 (en)
AT (1) ATE203020T1 (en)
CA (1) CA2043468A1 (en)
DE (1) DE69132651T2 (en)
DK (1) DK0460488T3 (en)
ES (1) ES2157887T3 (en)
GR (1) GR3036836T3 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998008517A2 (en) * 1996-08-26 1998-03-05 Takeda Chemical Industries, Ltd. Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
US5716944A (en) * 1994-07-04 1998-02-10 Takeda Chemical Industries, Ltd. Phosphonic acid compounds, their production and use
TW403757B (en) * 1994-12-28 2000-09-01 Takeda Chemical Industries Ltd Optically active benzothiepin derivative, its preparation and use
RU2188011C2 (en) * 1995-06-05 2002-08-27 Такеда Кемикал Индастриз, Лтд. Osteogenesis-activating pharmaceutical composition
US5910492A (en) * 1995-06-05 1999-06-08 Takeda Chemical Industries, Ltd. Osteogenic promoting pharmaceutical composition
AU6471896A (en) * 1995-07-24 1997-02-18 Takeda Chemical Industries Ltd. Production of optically active benzothiepin salts
WO1998015263A2 (en) * 1996-10-09 1998-04-16 Takeda Chemical Industries, Ltd. A method for producing a microparticle
AU4165699A (en) * 1998-06-15 2000-01-05 Takeda Chemical Industries Ltd. Composition for treating cartilage disease
AU5194999A (en) 1998-08-07 2000-02-28 Takeda Chemical Industries Ltd. Benzothiepin derivatives, process for the preparation of the same and uses thereof
WO2000009100A2 (en) * 1998-08-12 2000-02-24 Takeda Chemical Industries, Ltd. Benzothiepine compounds as enhancer of cell differentiation induction factor
EP1182195A4 (en) * 1999-05-07 2003-03-26 Takeda Chemical Industries Ltd Cyclic compounds and uses thereof
CN1537018A (en) 2001-05-23 2004-10-13 田边制药株式会社 Therapeutic compositions for repairing chondropathy
US20040146561A1 (en) 2001-05-23 2004-07-29 Naoki Sakurai Compositions for promoting healing of bone fracture
US20100221345A1 (en) 2006-01-18 2010-09-02 National University Corporation Tokyo Medical And Osteogenic biomaterial containing osteogenesis promoting substance and nanogel
KR102062762B1 (en) * 2017-10-18 2020-01-06 이경민 Dough flake forming apparatus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636049A (en) * 1969-11-26 1972-01-18 Pfizer Isothiochroman carboxamides
DK656789A (en) * 1988-12-28 1990-06-29 Takeda Chemical Industries Ltd BENZOHETEROCYCLIC COMPOUNDS

Also Published As

Publication number Publication date
EP0460488B1 (en) 2001-07-11
GR3036836T3 (en) 2002-01-31
JP3165889B2 (en) 2001-05-14
ES2157887T3 (en) 2001-09-01
DE69132651T2 (en) 2001-10-25
ATE203020T1 (en) 2001-07-15
JP2992653B2 (en) 1999-12-20
JPH09176154A (en) 1997-07-08
DK0460488T3 (en) 2001-09-17
JPH04364179A (en) 1992-12-16
EP0460488A1 (en) 1991-12-11
CA2043468A1 (en) 1991-12-01

Similar Documents

Publication Publication Date Title
NO904377L (en) TRICYCLIC CARBAPNAM COMPOUNDS.
DE69132651D1 (en) Heterocyclic compounds containing sulfur
ES2090790T3 (en) GLYCOLIPID DERIVATIVES.
TW256832B (en)
ATE112770T1 (en) SULFUR CONTAINING HETEROCYCLIC COMPOUNDS.
DE68922765D1 (en) Substituted naphthalene compounds and liquid crystal compositions containing them.
AU2321688A (en) Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloalkanes
ES2074828T3 (en) DEGRADABLE COPOLIESTER OF 4-HYDROXY-PROLIN AND PHARMACEUTICAL COMPOSITION THAT CONTAINS IT.
NO305960B1 (en) Sulfur-containing and thio-substituted phosphonate compounds, a pharmaceutical composition comprising such a compound and the use thereof
ATE115545T1 (en) ARALKYLAMINE COMPOUNDS.
DK0601191T3 (en) Hitherto unknown tetracyclic compound
PT83334A (en) Process for the preparation of beta-lactam compounds
EP0401715A3 (en) Aminoketone compounds
ZA899821B (en) Novel compounds
DE69615814D1 (en) UCH-15 CONNECTIONS
ATE189813T1 (en) PROSTAGLANDIN-I ANALOGUE

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee